98 related articles for article (PubMed ID: 22721384)
1. The therapeutical potential of a novel pterocarpanquinone LQB-118 to target inhibitor of apoptosis proteins in acute myeloid leukemia cells.
de Souza Reis FR; de Faria FC; Castro CP; de Souza PS; da Cunha Vasconcelos F; Bello RD; da Silva AJ; Costa PR; Maia RC
Anticancer Agents Med Chem; 2013 Feb; 13(2):341-51. PubMed ID: 22721384
[TBL] [Abstract][Full Text] [Related]
2. The pterocarpanquinone LQB-118 induces apoptosis in acute myeloid leukemia cells of distinct molecular subtypes and targets FoxO3a and FoxM1 transcription factors.
Nestal de Moraes G; Castro CP; Salustiano EJ; Dumas ML; Costas F; Lam EW; Costa PR; Maia RC
Int J Oncol; 2014 Nov; 45(5):1949-58. PubMed ID: 25174716
[TBL] [Abstract][Full Text] [Related]
3. LQB-118, a pterocarpanquinone structurally related to lapachol [2-hydroxy-3-(3-methyl-2-butenyl)-1,4-naphthoquinone]: a novel class of agent with high apoptotic effect in chronic myeloid leukemia cells.
Maia RC; Vasconcelos FC; de Sá Bacelar T; Salustiano EJ; da Silva LF; Pereira DL; Moellman-Coelho A; Netto CD; da Silva AJ; Rumjanek VM; Costa PR
Invest New Drugs; 2011 Dec; 29(6):1143-55. PubMed ID: 20499132
[TBL] [Abstract][Full Text] [Related]
4. Insights into the Biological Evaluation of Pterocarpanquinones and Carbapterocarpans with Anti-tumor Activity against MDR Leukemias.
Rumjanek VM; Maia RC; Salustiano EJ; Costa PRR
Anticancer Agents Med Chem; 2019; 19(1):29-37. PubMed ID: 29692266
[TBL] [Abstract][Full Text] [Related]
5. The LQB-223 Compound Modulates Antiapoptotic Proteins and Impairs Breast Cancer Cell Growth and Migration.
Lemos LGT; Longo GMDC; Mendonça BDS; Robaina MC; Brum MCM; Cirilo CA; Gimba ERP; Costa PRR; Buarque CD; Nestal de Moraes G; Maia RC
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614718
[TBL] [Abstract][Full Text] [Related]
6. The pterocarpanquinone LQB‑118 compound induces apoptosis of cytarabine‑resistant acute myeloid leukemia cells.
Hancio T; Mazzoccoli L; Guimarães G; Robaina M; Mendonça BDS; Nestal De Moraes G; Monte-Mor BDCR; Mayumi Gutiyama L; De Carvalho LO; Netto CD; Costa PRR; De Faria FCC; Maia RC
Int J Oncol; 2021 Jun; 58(6):. PubMed ID: 33786613
[TBL] [Abstract][Full Text] [Related]
7. The pterocarpanquinone LQB 118 induces apoptosis in tumor cells through the intrinsic pathway and the endoplasmic reticulum stress pathway.
de Sá Bacelar T; da Silva AJ; Costa PR; Rumjanek VM
Anticancer Drugs; 2013 Jan; 24(1):73-83. PubMed ID: 22960938
[TBL] [Abstract][Full Text] [Related]
8. The pterocarpanquinone LQB-118 inhibits tumor cell proliferation by downregulation of c-Myc and cyclins D1 and B1 mRNA and upregulation of p21 cell cycle inhibitor expression.
Martino T; Magalhães FC; Justo GA; Coelho MG; Netto CD; Costa PR; Sabino KC
Bioorg Med Chem; 2014 Jun; 22(12):3115-22. PubMed ID: 24794748
[TBL] [Abstract][Full Text] [Related]
9. Influence of survivin-targeted therapy on chemosensitivity in the treatment of acute myeloid leukemia.
Huang J; Lyu H; Wang J; Liu B
Cancer Lett; 2015 Oct; 366(2):160-72. PubMed ID: 26123662
[TBL] [Abstract][Full Text] [Related]
10. The orally active pterocarpanquinone LQB-118 exhibits cytotoxicity in prostate cancer cell and tumor models through cellular redox stress.
Martino T; Kudrolli TA; Kumar B; Salviano I; Mencalha A; Coelho MGP; Justo G; Costa PRR; Sabino KCC; Lupold SE
Prostate; 2018 Feb; 78(2):140-151. PubMed ID: 29105806
[TBL] [Abstract][Full Text] [Related]
11. NFκB pathway and microRNA-9 and -21 are involved in sensitivity to the pterocarpanquinone LQB-118 in different CML cell lines.
de Faria FC; Leal ME; Bernardo PS; Costa PR; Maia RC
Anticancer Agents Med Chem; 2015; 15(3):345-52. PubMed ID: 25964959
[TBL] [Abstract][Full Text] [Related]
12. Targeting survivin with YM155 (Sepantronium Bromide): a novel therapeutic strategy for paediatric acute myeloid leukaemia.
Smith AM; Little EB; Zivanovic A; Hong P; Liu AK; Burow R; Stinson C; Hallahan AR; Moore AS
Leuk Res; 2015 Apr; 39(4):435-44. PubMed ID: 25659731
[TBL] [Abstract][Full Text] [Related]
13. siRNA-mediated silencing of survivin inhibits proliferation and enhances etoposide chemosensitivity in acute myeloid leukemia cells.
Karami H; Baradaran B; Esfahani A; Estiar MA; Naghavi-Behzad M; Sakhinia M; Sakhinia E
Asian Pac J Cancer Prev; 2013; 14(12):7719-24. PubMed ID: 24460358
[TBL] [Abstract][Full Text] [Related]
14. LQB-118, an orally active pterocarpanquinone, induces selective oxidative stress and apoptosis in Leishmania amazonensis.
Ribeiro GA; Cunha-Júnior EF; Pinheiro RO; da-Silva SA; Canto-Cavalheiro MM; da Silva AJ; Costa PR; Netto CD; Melo RC; Almeida-Amaral EE; Torres-Santos EC
J Antimicrob Chemother; 2013 Apr; 68(4):789-99. PubMed ID: 23288404
[TBL] [Abstract][Full Text] [Related]
15. siRNA-mediated inhibition of survivin gene enhances the anti-cancer effect of etoposide in U-937 acute myeloid leukemia cells.
Jafarlou M; Baradaran B; Shanehbandi D; Saedi TA; Jafarlou V; Ismail P; Othman F
Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):44-9. PubMed ID: 27262801
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory properties of pterocarpanquinone LQB-118 in mice.
Riça IG; Netto CD; Rennó MN; Abreu PA; Costa PRR; da Silva AJM; Cavalcante MCM
Bioorg Med Chem; 2016 Sep; 24(18):4415-4423. PubMed ID: 27492193
[TBL] [Abstract][Full Text] [Related]
17. [Expression of survivin and its location in bone marrow cells of childhood acute leukemia: relationship to therapeutic efficacy].
Hou Y; Hu Q; Liu AG; Zhang LQ; Liu SY
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Apr; 8(2):101-4. PubMed ID: 16613699
[TBL] [Abstract][Full Text] [Related]
18. Targeting of X-linked inhibitor of apoptosis protein or survivin by short interfering RNAs sensitize hepatoma cells to TNF-related apoptosis-inducing ligand- and chemotherapeutic agent-induced cell death.
Yamaguchi Y; Shiraki K; Fuke H; Inoue T; Miyashita K; Yamanaka Y; Saitou Y; Sugimoto K; Nakano T
Oncol Rep; 2005 Nov; 14(5):1311-6. PubMed ID: 16211302
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies.
Smolewski P; Robak T
Curr Mol Med; 2011 Nov; 11(8):633-49. PubMed ID: 21902653
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Studies Evaluating Subacute Toxicity and Therapeutic Efficacy of LQB-118 in Experimental Visceral Leishmaniasis.
Cunha-Júnior EF; Martins TM; Canto-Cavalheiro MM; Marques PR; Portari EA; Coelho MG; Netto CD; Costa PR; Sabino KC; Torres-Santos EC
Antimicrob Agents Chemother; 2016 Jun; 60(6):3794-801. PubMed ID: 27067332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
